About
Macrocyclic peptide therapeutics
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
17
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04708236Lead Sponsor
A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
PHASE1/PHASE2Withdrawn
Started: Apr 30, 2021 · Completed: Jul 31, 2021
NCT04286789Lead Sponsor
Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs
PHASE1Completed
17 participants
Started: Mar 22, 2021 · Completed: Oct 12, 2021
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...